Skip to main content

Animations

MJFF Publications

1411 - 1420 of 6516 Results
Title
Year
  • Year
  • 2019
  • 2020
  • 2025
  • 2017
  • 2021
  • 2022
  • 2016
  • 2018
  • 2018
  • 2020
  • Summary Details
    OPEN
    Title: An estimate of the total number of true human miRNAs
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/nar/gkz097
    Citation Count: 494
  • Summary Details
    OPEN
    Title: Three-Plane–assembled Deep Learning Segmentation of Gliomas
    Journal Name: Radiology: Artificial Intelligence
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1148/ryai.2020190011
    Citation Count: 24
  • Summary Details
    OPEN
    Title: A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-025-00889-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: RIC3 variants are not associated with Parkinson's disease in French-Canadians and French
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.01.005
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.28525
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Nicotine‐Mediated Rescue of α‐Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in Drosophila
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29283
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23192
    Citation Count: 78
  • Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration
    2018
    Summary Details
    OPEN
    Title: Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddy308
    Citation Count: 30
  • Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    2018
    Summary Details
    OPEN
    Title: Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27392
    Citation Count: 139
  • Summary Details
    OPEN
    Title: Induction of the Endoplasmic-Reticulum-Stress Response: MicroRNA-34a Targeting of the IRE1α-Branch
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells9061442
    Citation Count: 20
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.